Low Risk Myelodysplastic Syndromes clinical trials

Explore recruiting low risk myelodysplastic syndromes clinical trials.

Recruiting low risk myelodysplastic syndromes studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Low Risk Myelodysplastic Syndromes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ATOMYELO: Phase I study with dose-escalation and expansion evaluating the safety and efficacy of oral Arsenic (ATO) in low-risk Myelodysplastic Syndromes failing Erythropoiesis Stimulating Agents and Luspatercept (or ineligible for the latter)

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

An open-label, dose-escalation, dose-finding, and proof-of-concept trial of SP-420 in subjects with transfusion-dependent α- or β-thalassemia or low-risk myelodysplastic syndromes

Denmark, Greece, Italy, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Low Risk Myelodysplastic Syndromes trials by city

Low Risk Myelodysplastic Syndromes in Toronto Low Risk Myelodysplastic Syndromes in Vancouver Low Risk Myelodysplastic Syndromes in Montreal Low Risk Myelodysplastic Syndromes in Calgary Low Risk Myelodysplastic Syndromes in Edmonton Low Risk Myelodysplastic Syndromes in Ottawa Low Risk Myelodysplastic Syndromes in Winnipeg Low Risk Myelodysplastic Syndromes in Quebec City Low Risk Myelodysplastic Syndromes in Hamilton Low Risk Myelodysplastic Syndromes in Kitchener Low Risk Myelodysplastic Syndromes in London Low Risk Myelodysplastic Syndromes in Halifax Low Risk Myelodysplastic Syndromes in New York Low Risk Myelodysplastic Syndromes in Los Angeles Low Risk Myelodysplastic Syndromes in Chicago Low Risk Myelodysplastic Syndromes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease